Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer.
Yu H, Giai M, Diamandis E, Katsaros D, Sutherland D, Levesque M, Roagna R, Ponzone R, Sismondi P. Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer. Cancer Research 1995, 55: 2104-10. PMID: 7538047.Peer-Reviewed Original ResearchConceptsProstate-specific antigenIR-PSABreast cancerCox proportional hazards regression modelEstrogen receptor-negative patientsEstrogen receptor-positive tumorsProportional hazards regression modelsIndependent favorable prognostic markerReceptor-negative patientsNode-positive patientsFavorable prognostic indicatorSurvival of patientsReceptor-positive tumorsRelapse-free survivalBreast cancer patientsFemale breast cancerHazards regression modelsEarly disease stagesFavorable prognostic markerProstatic epithelial cellsPSA statusBetter prognosisPositive tumorsPrognostic valueDisease stageOral Contraceptive-induced Expression of Prostate-specific Antigen in the Female Breast (∗)
Yu H, Diamandis E, Monne M, Croce C. Oral Contraceptive-induced Expression of Prostate-specific Antigen in the Female Breast (∗). Journal Of Biological Chemistry 1995, 270: 6615-6618. PMID: 7534765, DOI: 10.1074/jbc.270.12.6615.Peer-Reviewed Original ResearchConceptsProstate-specific antigenImmunoreactive prostate-specific antigenNormal breast tissueBreast tissueBreast tumorsSeminal prostate-specific antigenFemale breast cancerFavorable prognostic markerRight breast tissueSteroid hormone stimulationBreast carcinoma cell linesOral contraceptivesBetter prognosisCarcinoma cell linesPrognostic markerProstatic adenocarcinomaBreast cancerPSA productionTumor markersProstatic tissueHormone stimulationProstatic proteinsFemale breastCytosolic extractsCDNA polymerase chain reaction products